Gregg Eure, MD

Articles by Gregg Eure, MD

Making Sense of the Reintervention Rate for BPH

ByGregg Eure, MD,LAURENCE A. LEVINE, MD

March 7th 2021

Letter: BPH guidelines may ignore FDA, insurance criteria

ByGregg Eure, MD

May 12th 2020

"As we seek to understand MIST retreatment rates, as Houlihan and Köhler suggest, we must rely upon real-world population data," writes Gregg Eure, MD, in a letter to the editor.

Latest Updated Articles

Making Sense of the Reintervention Rate for BPH
March 7th 2021
Letter: BPH guidelines may ignore FDA, insurance criteria
May 12th 2020

Gregg Eure, MD

Articles by Gregg Eure, MD

Making Sense of the Reintervention Rate for BPH

Letter: BPH guidelines may ignore FDA, insurance criteria

Latest Updated Articles

Trending on Urology Times

FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC

Testosterone deficiency: FAQs from the AUA guideline

Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice

Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer

From hype to practice: Urologists assess AI's real impact